Macintyre, Geoff http://orcid.org/0000-0003-3906-467X
Goranova, Teodora E. http://orcid.org/0000-0003-3848-2968
De Silva, Dilrini
Ennis, Darren
Piskorz, Anna M.
Eldridge, Matthew
Sie, Daoud http://orcid.org/0000-0001-6762-2582
Lewsley, Liz-Anne
Hanif, Aishah
Wilson, Cheryl
Dowson, Suzanne http://orcid.org/0000-0003-2511-1965
Glasspool, Rosalind M. http://orcid.org/0000-0002-5000-1680
Lockley, Michelle
Brockbank, Elly
Montes, Ana
Walther, Axel
Sundar, Sudha
Edmondson, Richard
Hall, Geoff D.
Clamp, Andrew
Gourley, Charlie
Hall, Marcia
Fotopoulou, Christina
Gabra, Hani
Paul, James
Supernat, Anna
Millan, David
Hoyle, Aoisha
Bryson, Gareth
Nourse, Craig
Mincarelli, Laura
Sanchez, Luis Navarro
Ylstra, Bauke
Jimenez-Linan, Mercedes
Moore, Luiza
Hofmann, Oliver
Markowetz, Florian http://orcid.org/0000-0002-2784-5308
McNeish, Iain A. http://orcid.org/0000-0002-9387-7586
Brenton, James D. http://orcid.org/0000-0002-5738-6683
Article History
Received: 4 September 2017
Accepted: 19 June 2018
First Online: 13 August 2018
Competing interests
: The following authors declare competing interests: C.G. has the following personal interests: Roche, AstraZeneca, Tesaro, Clovis, Foundation One, Nucana, received research funding from: AstraZeneca, Novartis, Aprea, Nucana, Tesaro and is a named co-inventor on five patents (issued: PCT/US2012/040805; pending: PCT/GB2013/053202, 1409479.1, 1409476.7 and 1409478.3). H.G. is employed by AstraZeneca. I.A.M. has the following personal interest: Clovis Oncology. J.D.B. is a cofounder and shareholder of Inivata Ltd (a cancer genomics company that commercializes ctDNA analysis). All other authors declare no competing interests.